TRLS.L
Price:
$1.85
Market Cap:
$3.82M
Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers TrellusElevate, a proprietary HIPAA-compliant technology platform to coordinate and deliver personalized care remotely through telemedicine. Its platform provides patients with access to a care team, educational content resources, and remote monitoring capabilities for the treatment of inflammatory bowel diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis. The company was founded in 2020 and is headquartered in White Plains, New York.[Read more]
Industry
Medical - Healthcare Information Services
IPO Date
2021-05-31
Stock Exchange
LSE
Ticker
TRLS.L
According to Trellus Health plc’s latest financial reports and current stock price. The company's current Enterprise Value is -4227422.48. This represents a change of 28.80% compared to the average of -3282059.19 of the last 4 quarters.
The mean historical Enterprise Value of Trellus Health plc over the last ten years is 31.36M. The current -4227422.48 Enterprise Value has changed -1448.02% with respect to the historical average. Over the past ten years (40 quarters), TRLS.L's Enterprise Value was at its highest in in the December 2021 quarter at 69.81M. The Enterprise Value was at its lowest in in the December 2023 quarter at -5483528.86.
Average
31.36M
Median
26.56M
Minimum
-5483996.49
Maximum
77.80M
Discovering the peaks and valleys of Trellus Health plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Enterprise Value = 77.80M
Minimum Annual Increase = -1362.39%
Minimum Annual Enterprise Value = -5483996.49
Year | Enterprise Value | Change |
---|---|---|
2023 | -5483996.49 | -1362.39% |
2022 | 434.41K | -99.18% |
2021 | 52.69M | -32.27% |
The current Enterprise Value of Trellus Health plc (TRLS.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
15.88M
5-year avg
31.36M
10-year avg
31.36M
Trellus Health plc’s Enterprise Value is less than Verici Dx plc (-1908653.23), less than EKF Diagnostics Holdings plc (85.70M), less than Renalytix Plc (26.40M), less than Belluscura plc (5.53M), less than Poolbeg Pharma PLC (1.94M),
Company | Enterprise Value | Market cap |
---|---|---|
-1908653.23 | $3.64M | |
85.70M | $95.28M | |
26.40M | $27.32M | |
5.53M | $5.02M | |
1.94M | $12.00M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Trellus Health plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Trellus Health plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Trellus Health plc's Enterprise Value?
What is the highest Enterprise Value for Trellus Health plc (TRLS.L)?
What is the 3-year average Enterprise Value for Trellus Health plc (TRLS.L)?
What is the 5-year average Enterprise Value for Trellus Health plc (TRLS.L)?
How does the current Enterprise Value for Trellus Health plc (TRLS.L) compare to its historical average?